Phimume® heart pump for high risk patients
Part of Heart & circulation clinical trials.
This trial tests a new device called Phimume® that helps your heart pump blood. It is for people with severe heart failure who cannot have standard open-heart surgery because it is too risky. The device is placed without cutting open your chest.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 90 years old and not pregnant or breastfeeding.
- Standard open-heart surgery is too risky for you, or you have chosen not to have it.
- Your heart's pumping ability (ejection fraction) is 35% or less, and you have a blocked heart artery that needs treatment, or your ejection fraction is 30% or less with blockages in three main heart arteries.
- You have not had a cardiac arrest or a major heart attack in the last 24 hours, and you are not in cardiogenic shock.
- You do not have serious kidney, liver, or blood problems that would make the device unsafe.
- You are willing to take part in the study, understand its purpose, and attend follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new device called the VentriCure that helps the heart pump blood. It is for people with severe coronary artery disease and a weak heart who cannot have bypass surgery or choose not to.
This trial tests a device called Ventiflow LP that supports the heart during high-risk stent placement (PCI) in people whose hearts are weak or have complex blockages. It may be an option if surgery is too risky or you prefer not to have it.
This trial tests a temporary heart pump (called the KARDION Cory P4) used during a high-risk angioplasty (stenting) procedure. The pump helps keep blood flowing in patients whose heart is weak or who have complex blockages, aiming to make the procedure safer.
This study looks at treatment options for adults with significantly reduced heart pumping strength and extensive coronary artery disease. It may help people who are at higher risk due to widespread blocked heart arteries, but eligibility depends on recent heart events and bleeding risk.
This trial tests whether a small heart-support device called Impella CP helps protect your heart during complex coronary angioplasty (a procedure to open blocked heart arteries). You may qualify if you have weak heart function and specific patterns of blocked arteries that make the procedure higher risk.
This trial tests a temporary heart pump to support patients with weak hearts (ejection fraction 35% or less) who need a high-risk stent procedure instead of bypass surgery. The pump may help keep blood flowing during the procedure.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.